{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:45:07Z","timestamp":1786981507769,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Stereotactic radiosurgery (SRS) is frequently used in the management of brain metastasis patients. However, there is an urgent need to evaluate post-treatment outcomes and quality of life metrics for patients undergoing SRS for brain metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The NeuroPoint Alliance (NPA) SRS Quality Registry conducted prospective enrollment of patients undergoing SRS from 2017 to 2024. Patients with brain metastases from lung cancer, breast cancer, and melanoma were included in the analysis. Outcomes of interest included quality of life metrics, as captured by the five-dimension Euro-QOL (EQ-5D) at 6\u201312 months and last record follow-up, overall survival, local progression, out-of-field progression, and overall intracranial progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>522 patients comprised our analytic cohort, and 315 patients had available EQ-5D data at the time of SRS and final follow-up. 264 (47.8%), 197 (35.7%), and 91 (16.5%) patients had 1, 2\u20134, and 5\u201314 lesions pre-SRS, respectively. The median overall survival time from diagnosis was 27.3 months. The median time-to-local progression was not reached. At final follow-up, 107 (34.0%) patients had improvement, 51 (16.2%) patients had stable, and 113 patients (35.9%) had worsening EQ-5D scores when compared to baseline. For 44 (13.9%) patients mixed responses across the EQ-5D indices were reported. Linear regression analysis showed that male sex, smoking status, primary tumor type, time-to-overall progression, cumulative intracranial tumor volume (CITV), and baseline EQ-5D were statistically significantly associated with EQ-5D single index at the final follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Real-world data from the SRS NPA Registry demonstrated that most patients with brain metastasis had no change or improvement in quality of life after SRS. Baseline EQ-5D was predictive of EQ-5D single index at final follow-up, and, as such, EQ-5D at baseline would be a valuable assessment measure for brain metastasis patients undergoing SRS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11060-024-04854-5","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T10:03:39Z","timestamp":1729505019000},"page":"383-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry"],"prefix":"10.1007","volume":"171","author":[{"given":"Duy Q.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrah E.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimball A.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Katsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo E.","family":"Fadul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"4854_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","volume":"14","author":"L Nayak","year":"2012","unstructured":"Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48\u201354","journal-title":"Curr Oncol Rep"},{"key":"4854_CR2","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","volume":"19","author":"DN Cagney","year":"2017","unstructured":"Cagney DN, Martin AM, Catalano PJ et al (2017) Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro-Oncol 19:1511\u20131521","journal-title":"Neuro-Oncol"},{"key":"4854_CR3","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3171\/2020.4.JNS20788","volume":"134","author":"A Bunevicius","year":"2020","unstructured":"Bunevicius A, Lavezzo K, Shabo L et al (2020) Quality-of-life trajectories after stereotactic radiosurgery for brain metastases. J Neurosurg 134:1791\u20131799","journal-title":"J Neurosurg"},{"key":"4854_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11060-019-03186-z","volume":"143","author":"E Verhaak","year":"2019","unstructured":"Verhaak E, Gehring K, Hanssens PEJ et al (2019) Health-related quality of life of patients with brain metastases selected for stereotactic radiosurgery. J Neurooncol 143:537\u2013546","journal-title":"J Neurooncol"},{"key":"4854_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0733-8619(02)00035-X","volume":"21","author":"AB Lassman","year":"2003","unstructured":"Lassman AB, DeAngelis LM (2003) Brain metastases. Neurol Clin 21:1\u201323","journal-title":"Neurol Clin"},{"key":"4854_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11060-022-04067-8","volume":"159","author":"A Bunevicius","year":"2022","unstructured":"Bunevicius A, Donovan L, Sheehan J (2022) Health-related quality of life trajectories after stereotactic radiosurgery for brain metastases: a systematic review. J Neurooncol 159:319\u2013331","journal-title":"J Neurooncol"},{"key":"4854_CR7","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1016\/S1470-2045(16)30510-1","volume":"17","author":"A Bottomley","year":"2016","unstructured":"Bottomley A, Pe M, Sloan J et al (2016) Analyzing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Lancet Oncol 17:e510\u2013e514","journal-title":"Lancet Oncol"},{"key":"4854_CR8","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.21037\/apm.2017.06.11","volume":"6","author":"KL Zeng","year":"2017","unstructured":"Zeng KL, Raman S, Sahgal A et al (2017) Patient preference for stereotactic radiosurgery plus or minus whole brain radiotherapy for the treatment of brain metastases. Ann Palliat Med 6:S155\u2013S160","journal-title":"Ann Palliat Med"},{"key":"4854_CR9","first-page":"1","volume":"1","author":"GD Michalopoulos","year":"2023","unstructured":"Michalopoulos GD, Katsos K, Grills IS et al (2023) Stereotactic radiosurgery in the management of non\u2013small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry. J Neurosurg 1:1\u201310","journal-title":"J Neurosurg"},{"key":"4854_CR10","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.3171\/2018.8.JNS181599","volume":"131","author":"JP Sheehan","year":"2018","unstructured":"Sheehan JP, Grills I, Chiang VL et al (2018) Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry. J Neurosurg 131:1848\u20131854","journal-title":"J Neurosurg"},{"key":"4854_CR11","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037\u20131044","journal-title":"Lancet Oncol"},{"key":"4854_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11060-023-04553-7","volume":"166","author":"JP Sheehan","year":"2024","unstructured":"Sheehan JP, Michalopoulos GD, Katsos K et al (2024) The NeuroPoint alliance SRS & tumor QOD registries. J Neurooncol 166:257\u2013264","journal-title":"J Neurooncol"},{"key":"4854_CR13","unstructured":"AANS Stereotactic Radiosurgery Registry (2024) Neuropoint, https:\/\/www.neuropoint.org\/stereotactic-radiosurgery-registry\/ (accessed 13"},{"key":"4854_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group (1990) EuroQol\u2013a new facility for the measurement of health-related quality of life. Health Policy Amst Neth 16:199\u2013208","journal-title":"Health Policy Amst Neth"},{"key":"4854_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1200\/JCO.1984.2.3.187","volume":"2","author":"CC Schag","year":"1984","unstructured":"Schag CC, Heinrich RL, Ganz PA (1984) Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol off J Am Soc Clin Oncol 2:187\u2013193","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"4854_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/neuros\/nyx380","volume":"83","author":"BR Hirshman","year":"2018","unstructured":"Hirshman BR, Wilson BR, Ali MA et al (2018) Cumulative intracranial tumor volume augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in patients with Melanoma Cerebral Metastases. Neurosurgery 83:237\u2013244","journal-title":"Neurosurgery"},{"key":"4854_CR17","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16:e270\u2013278","journal-title":"Lancet Oncol"},{"key":"4854_CR18","doi-asserted-by":"publisher","first-page":"590980","DOI":"10.3389\/fonc.2020.590980","volume":"10","author":"D Oft","year":"2021","unstructured":"Oft D, Schmidt MA, Weissmann T et al (2021) Volumetric regression in Brain metastases after Stereotactic Radiotherapy: Time Course, Predictors, and significance. Front Oncol 10:590980","journal-title":"Front Oncol"},{"key":"4854_CR19","doi-asserted-by":"publisher","unstructured":"Devlin PDN, Parkin D, Janssen B (2020) An Introduction to EQ-5D Instruments and Their Applications. In: Methods for Analysing and Reporting EQ-5D Data. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-47622-9_1","DOI":"10.1007\/978-3-030-47622-9_1"},{"key":"4854_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","volume":"12","author":"V Gondi","year":"2022","unstructured":"Gondi V, Bauman G, Bradfield L et al (2022) Radiation Therapy for Brain metastases: an ASTRO Clinical Practice Guideline. Pract Radiat Oncol 12:265\u2013282","journal-title":"Pract Radiat Oncol"},{"key":"4854_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K (2011) Mice: multivariate imputation by chained equations in R. J Stat Softw 45:1\u201367","journal-title":"J Stat Softw"},{"key":"4854_CR22","unstructured":"R: The R Project for Statistical Computing, https:\/\/www.r-project.org\/ (accessed 16 (2024)"},{"key":"4854_CR23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hec.1608","volume":"19","author":"NJ Devlin","year":"2010","unstructured":"Devlin NJ, Parkin D, Browne J (2010) Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data. Health Econ 19:886\u2013905","journal-title":"Health Econ"},{"key":"4854_CR24","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3171\/2015.10.JNS15801","volume":"126","author":"BS Skeie","year":"2017","unstructured":"Skeie BS, Eide GE, Flateb\u00f8 M et al (2017) Quality of life is maintained using Gamma Knife radiosurgery: a prospective study of a brain metastases patient cohort. J Neurosurg 126:708\u2013725","journal-title":"J Neurosurg"},{"key":"4854_CR25","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00432-020-03400-w","volume":"147","author":"E Verhaak","year":"2021","unstructured":"Verhaak E, Schimmel WCM, Gehring K et al (2021) Health-related quality of life after Gamma Knife radiosurgery in patients with 1\u201310 brain metastases. J Cancer Res Clin Oncol 147:1157\u20131167","journal-title":"J Cancer Res Clin Oncol"},{"key":"4854_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3171\/jns.2002.97.supplement_5.0507","volume":"97","author":"TS Vesagas","year":"2002","unstructured":"Vesagas TS, Aguilar JA, Mercado ER et al (2002) Gamma knife radiosurgery and brain metastases: local control, survival, and quality of life. J Neurosurg 97:507\u2013510","journal-title":"J Neurosurg"},{"key":"4854_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3171\/2017.2.JNS161659","volume":"129","author":"S Bragstad","year":"2017","unstructured":"Bragstad S, Flateb\u00f8 M, Natvig GK et al (2017) Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study. J Neurosurg 129:71\u201383","journal-title":"J Neurosurg"},{"key":"4854_CR28","first-page":"35","volume":"5","author":"DM Randolph","year":"2017","unstructured":"Randolph DM, McTyre E, Klepin H et al (2017) Impact of radiosurgical management of geriatric patients with brain metastases: clinical and quality of life outcomes. J Radiosurgery SBRT 5:35\u201342","journal-title":"J Radiosurgery SBRT"},{"key":"4854_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/neuros\/nyw166","volume":"81","author":"JA Miller","year":"2017","unstructured":"Miller JA, Kotecha R, Barnett GH et al (2017) Quality of life following stereotactic radiosurgery for single and multiple brain metastases. Neurosurgery 81:147\u2013155","journal-title":"Neurosurgery"},{"key":"4854_CR30","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1200\/JCO.1998.16.4.1594","volume":"16","author":"SD Passik","year":"1998","unstructured":"Passik SD, Dugan W, McDonald MV et al (1998) Oncologists\u2019 recognition of depression in their patients with cancer. J Clin Oncol 16:1594\u20131600","journal-title":"J Clin Oncol"},{"key":"4854_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00127-019-01763-1","volume":"55","author":"E Adjei Boakye","year":"2020","unstructured":"Adjei Boakye E, Osazuwa-Peters N, Mohammed KA et al (2020) Prevalence and factors associated with diagnosed depression among hospitalized cancer patients with metastatic disease. Soc Psychiatry Psychiatr Epidemiol 55:15\u201323","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"4854_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3171\/sup.2005.102.s_supplement.0075","volume":"102","author":"M Gerosa","year":"2005","unstructured":"Gerosa M, Nicolato A, Foroni R et al (2005) Analysis of long-term outcomes and prognostic factors in patients with non\u2014small cell lung cancer brain metastases treated by gamma knife radiosurgery. J Neurosurg 102:75\u201380","journal-title":"J Neurosurg"},{"key":"4854_CR33","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.3390\/cancers15123255","volume":"15","author":"CE Fadul","year":"2023","unstructured":"Fadul CE, Sarai G, Bovi JA et al (2023) Relevance of the updated recursive partitioning analysis (U-RPA) classification in the Contemporary Care of patients with brain metastases. Cancers 15:3255","journal-title":"Cancers"},{"key":"4854_CR34","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s11136-019-02156-2","volume":"28","author":"RH Ophuis","year":"2019","unstructured":"Ophuis RH, Janssen MF, Bonsel GJ et al (2019) Health-related quality of life in injury patients: the added value of extending the EQ-5D-3L with a cognitive dimension. Qual Life Res 28:1941\u20131949","journal-title":"Qual Life Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04854-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04854-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04854-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T19:07:18Z","timestamp":1735844838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04854-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4854"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04854-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study, and no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}